| Rac activation and inactivation control plasticity of tumor cell movement V Sanz-Moreno, G Gadea, J Ahn, H Paterson, P Marra, S Pinner, E Sahai, ... Cell 135 (3), 510-523, 2008 | 1116 | 2008 |
| Loss of p53 promotes RhoA–ROCK-dependent cell migration and invasion in 3D matrices G Gadea, M de Toledo, C Anguille, P Roux The Journal of cell biology 178 (1), 23-30, 2007 | 295 | 2007 |
| DOCK10-mediated Cdc42 activation is necessary for amoeboid invasion of melanoma cells G Gadea, V Sanz-Moreno, A Self, A Godi, CJ Marshall Current biology 18 (19), 1456-1465, 2008 | 237 | 2008 |
| Dock-family exchange factors in cell migration and disease G Gadea, A Blangy European journal of cell biology 93 (10-12), 466-477, 2014 | 217 | 2014 |
| Control of cell migration: a tumour suppressor function for p53? L Roger, G Gadea, P Roux Biology of the Cell 98 (3), 141-152, 2006 | 182 | 2006 |
| RBFOX2 is an important regulator of mesenchymal tissue-specific splicing in both normal and cancer tissues JP Venables, JP Brosseau, G Gadea, R Klinck, P Prinos, JF Beaulieu, ... Molecular and cellular biology 33 (2), 396-405, 2013 | 164 | 2013 |
| The South Pacific epidemic strain of Zika virus replicates efficiently in human epithelial A549 cells leading to IFN-β production and apoptosis induction E Frumence, M Roche, P Krejbich-Trotot, C El-Kalamouni, B Nativel, ... Virology 493, 217-226, 2016 | 156 | 2016 |
| MBNL1 and RBFOX2 cooperate to establish a splicing programme involved in pluripotent stem cell differentiation JP Venables, L Lapasset, G Gadea, P Fort, R Klinck, M Irimia, E Vignal, ... Nature communications 4 (1), 2480, 2013 | 149 | 2013 |
| A novel function for Cyclin A2: control of cell invasion via RhoA signaling N Arsic, N Bendris, M Peter, C Begon-Pescia, C Rebouissou, G Gadéa, ... Journal of Cell Biology 196 (1), 147-162, 2012 | 136 | 2012 |
| Regulation of Cdc42‐mediated morphological effects: a novel function for p53 G Gadéa, L Lapasset, C Gauthier‐Rouvière, P Roux The EMBO journal, 2002 | 123 | 2002 |
| A robust method for the rapid generation of recombinant Zika virus expressing the GFP reporter gene G Gadea, S Bos, P Krejbich-Trotot, E Clain, W Viranaicken, ... Virology 497, 157-162, 2016 | 102 | 2016 |
| The flavonoid isoquercitrin precludes initiation of Zika virus infection in human cells A Gaudry, S Bos, W Viranaicken, M Roche, P Krejbich-Trotot, G Gadea, ... International journal of molecular sciences 19 (4), 1093, 2018 | 84 | 2018 |
| Probing molecular insights into Zika virus–host interactions I Lee, S Bos, G Li, S Wang, G Gadea, P Desprès, RY Zhao Viruses 10 (5), 233, 2018 | 77 | 2018 |
| The p53 isoform Δ133p53β promotes cancer stem cell potential N Arsic, G Gadea, EL Lagerqvist, M Busson, N Cahuzac, C Brock, ... Stem cell reports 4 (4), 531-540, 2015 | 73 | 2015 |
| Cooperative anti-invasive effect of Cdc42/Rac1 activation and ROCK inhibition in SW620 colorectal cancer cells with elevated blebbing activity M de Toledo, C Anguille, L Roger, P Roux, G Gadea PloS one 7 (11), e48344, 2012 | 61 | 2012 |
| The structural proteins of epidemic and historical strains of Zika virus differ in their ability to initiate viral infection in human host cells S Bos, W Viranaicken, J Turpin, C El-Kalamouni, M Roche, ... Virology 516, 265-273, 2018 | 59 | 2018 |
| TNFα induces sequential activation of Cdc42-and p38/p53-dependent pathways that antagonistically regulate filopodia formation G Gadea, L Roger, C Anguille, M de Toledo, V Gire, P Roux Journal of cell science 117 (26), 6355-6364, 2004 | 58 | 2004 |
| TP53 drives invasion through expression of its Δ133p53β variant G Gadea, N Arsic, K Fernandes, A Diot, SM Joruiz, S Abdallah, V Meuray, ... Elife 5, e14734, 2016 | 57 | 2016 |
| Greatwall promotes cell transformation by hyperactivating AKT in human malignancies J Vera, L Lartigue, S Vigneron, G Gadea, V Gire, M Del Rio, I Soubeyran, ... Elife 4, e10115, 2015 | 57 | 2015 |
| Subversion of the heme oxygenase-1 antiviral activity by zika virus C El Kalamouni, E Frumence, S Bos, J Turpin, B Nativel, W Harrabi, ... Viruses 11 (1), 2, 2018 | 51 | 2018 |
Dr Sophie E. Acton (Pinner)Laboratory for Molecular Cell Biology, University College LondonVerified email at ucl.ac.uk
